Catalyst Wire Dossier Catalyst Wire Dossier

Direct lentiviral injection gene therapy for Metachromatic Leukodystrophy

· Shenzhen Geno-Immune Medical Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Direct lentiviral injection gene therapy for Metachromatic Leukodystrophy, covering 2025-06-26 to 2025-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Direct Lentiviral Injection Gene Therapy for MLD [NA]

See pricing